NCT00598637View on ClinicalTrials.gov

Drug-eluting Stents to Treat Unprotected Coronary Left Main Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

650

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

September 30, 2012

Study Completion Date

February 28, 2013

Conditions
Coronary Disease
Interventions
DEVICE

Everolimus-eluting stent (Xience)

stent is implanted due to randomization

DEVICE

Zotarolimus-eluting stent (Endeavor Resolute)

stent is implanted due to randomization

Trial Locations (4)

44100

Azienda Ospedaliero Universitaria di Ferrara, Ferrara

80636

Deutsches Herzzentrum Muenchen, Munich

81675

First Medizinische Klinik, Klinikum rechts der Isar, Munich

Unknown

Bad Segeberger Kliniken, Bad Segeberg

All Listed Sponsors
collaborator

Technical University of Munich

OTHER

lead

Deutsches Herzzentrum Muenchen

OTHER

NCT00598637 - Drug-eluting Stents to Treat Unprotected Coronary Left Main Disease | Biotech Hunter | Biotech Hunter